ALI, Faraz
To:REGENXBIO Inc., CBO (March)
Execs On The Move, March 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
More from Archive
More from In Vivo
• By
From billion-dollar COVID antibody to a strategic reset, Marianne De Backer is navigating Vir's comeback through pipeline focus and disciplined leadership.
• By
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
• By
A Q&A with DeAnn Smith, partner and co-chair of the Patent Trial and Appeal Board Proceedings Practice Group at law firm Foley Hoag.